or
forgot password

    • cancer clinical trials in columbia, MO

    • Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia
    Local Institution
    Columbia, Missouri
    Chronic Myelogenous Leukemia
    Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib
    Local Institution
    Columbia, Missouri
    Chronic Myeloid Leukemia, Philadelphia-Positive Myeloid Leukemia
    Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.
    Pfizer Investigational Site
    Columbia, Missouri 65201
    Colorectal Neoplasms
    Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia
    Local Institution
    Columbia, Missouri
    Chronic Myeloid Leukemia, Philadelphia-Positive Myeloid Leukemia
    Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer
    University of Missouri
    Columbia, Missouri 65212
    Lung Cancer, Non Small Cell Lung Carcinoma
    Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer
    University of Missouri / Ellis Fischel Cancer Center
    Columbia, Missouri 65203-3299
    Small Cell Lung Cancer
    A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer
    University of Missouri, Urology, Deptof Surgery
    Columbia, Missouri 65212
    Prostate Cancer
    Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer

    Columbia, Missouri 65203
    Adenocarcinoma, Non-Small-Cell Lung Carcinoma, Lung Neoplasms
    Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).
    Pfizer Investigational Site
    Columbia, Missouri 65201
    Colorectal Neoplasms
    Study Evaluating HKI-272 in Tumors

    Columbia, Missouri 65203
    Breast Neoplasms
    Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer
    Pfizer Investigational Site
    Columbia, Missouri 65201
    Carcinoma, Non-Small-Cell Lung
    Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

    Columbia, Missouri 65203
    Acute Myeloid Leukemia
    Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer
    Ellis Fisher Cancer Center
    Columbia, Missouri 65203
    Carcinoma, Non-Small-Cell Lung
    A Phase III Trial For Patients With Metastatic Breast Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician.
    Columbia, Missouri
    Breast Cancer, Breast Neoplasms, Cancer of the Breast
    Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
    Pfizer Investigational Site
    Columbia, Missouri 65201
    Osteoporosis
    Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer
    Missouri Cancer Associates
    Columbia, Missouri 65201
    Colorectal Cancer Metastatic
    Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC
    Pfizer Investigational Site
    Columbia, Missouri 65201
    Carcinoma, Non-Small-Cell Lung
    A Long-term Safety Study of Infliximab (Remicade)

    Columbia, Missouri 65203
    Arthritis, Rheumatoid, Crohn Disease, Psoriasis
    Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer

    Columbia, Missouri 65203
    Breast Neoplasms, Neoplasms, Hormone-Dependent
    A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.
    Columbia Comprehensive Cancer Care Clinics
    Columbia, Missouri 65201
    NSCLC
    DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])
    Missouri Cancer Associates

    Trial Locations
    Missouri Cancer Associates
    University of Missouri, Ellis Fischel Cancer Center
    Prostate Cancer
    Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
    Missouri Cancer Associates
    Columbia, Missouri 65201
    Metastatic Breast Cancer
    Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer
    Pfizer Investigational Site
    Columbia, Missouri 65201
    Carcinoma, Non-Small-Cell Lung
    A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer
    University of Missouri, Columbia
    Columbia, Missouri 65211
    Carcinoma, Non-Small-Cell Lung
    A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer
    Ellis Fischel Cancer Center
    Columbia, Missouri 65203
    Metastatic Breast Cancer
    Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors
    Pfizer Investigational Site
    Columbia, Missouri 65201
    Gastrointestinal Stromal Tumor
    Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
    Ellis Fischel Cancer Center at University of Missouri - Columbia
    Columbia, Missouri 65203
    Leukemia
    Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases
    Pfizer Investigational Site
    Columbia, Missouri 65201
    Non-Small Cell Lung Cancer
    Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy
    Missouri Cancer Associates
    Columbia, Missouri 65201
    Small Cell Lung Cancer
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    University Of Missouri-Columbia
    Columbia, Missouri 65212
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer
    Ellis Fischel Cancer Center
    Columbia, Missouri 65203
    Metastatic Pancreatic Cancer
    First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
    Missouri Cancer Associates

    Trial Locations
    Missouri Cancer Associates
    University Of Missouri Healthcare/Ellis Fischel Cancer Ctr
    Bladder Cancer, Transitional Cell Carcinoma, Metastasis
    Multi-Center Human Alert Trial to Prevent DVT and PE
    University of Missouri
    Columbia, Missouri 65212
    Pulmonary Embolism, Deep Vein Thrombosis, Cancer, Surgery